Lilly plans to invest $27 billion in new US plants as Trump threatens pharmaceutical tariffs
Eli Lilly plans to spend at least $27 billion to build four new manufacturing plants in the U.S., the drugmaker said at a Washington press conference on Wednesday, as it grapples with the threat of drug import duties from the Trump administration.
Drugmaker Eli Lilly plans to build four new manufacturing plants in the U.S., a $27 billion investment that the company ...
In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...
Eli Lilly Currently Up Seven Consecutive Days, On Track for Longest Winning Streak Since October 2023 — Data Talk Eli Lilly and Company (LLY) is currently at $915.07, up $13.27 or 1.47% --Would be ...
Eli Lilly said it has launched new doses of its obesity treatment drug and reduced its prices.
Eli Lilly has unveiled a $27bn investment in US manufacturing facilities as the pharmaceutical industry prepares for the threat of tariffs and mounts a charm offensive aimed at President Donald ...
The pharma group has just announced that it will build four new manufacturing facilities in the US – at a cost of around $27 ...
Eli Lilly (Lilly) has agreed to make a $10m upfront payment for full worldwide rights to San Diego-based Organovo Holdings’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback